Ontrak, Inc. (OTRK)
USD 1.38
(-4.94%)
USD 1.38
(-4.94%)
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2023 | 8.8 Million USD | -65.72% |
| 2022 | 7.05 Million USD | -86.67% |
| 2021 | 52.91 Million USD | 34.88% |
| 2020 | 39.23 Million USD | 167.13% |
| 2019 | 14.68 Million USD | 261.93% |
| 2018 | 4.05 Million USD | 206.03% |
| 2017 | 1.32 Million USD | -44.86% |
| 2016 | 2.4 Million USD | 784.19% |
| 2015 | 272 Thousand USD | -62.69% |
| 2014 | 729 Thousand USD | 3936.84% |
| 2013 | -19 Thousand USD | 93.09% |
| 2012 | -275 Thousand USD | 9.54% |
| 2011 | -304 Thousand USD | -257.51% |
| 2010 | 193 Thousand USD | -81.1% |
| 2009 | 1.02 Million USD | -66.15% |
| 2008 | 3.01 Million USD | -51.9% |
| 2007 | 6.27 Million USD | 103.04% |
| 2006 | 3.08 Million USD | 138.2% |
| 2005 | -8.08 Million USD | -64.12% |
| 2004 | -4.92 Million USD | -6666.67% |
| 2003 | 75 Thousand USD | 33.65% |
| 2002 | 56.11 Thousand USD | -82.08% |
| 2001 | 313.12 Thousand USD | 0.0% |
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2024 Q1 | 1.4 Million USD | -5.95% |
| 2024 Q2 | 1.28 Million USD | 14.21% |
| 2023 Q1 | 1.68 Million USD | 9.43% |
| 2023 Q3 | 2.67 Million USD | 24.07% |
| 2023 Q4 | 1.49 Million USD | -44.07% |
| 2023 FY | 2.41 Million USD | -65.72% |
| 2023 Q2 | 2.15 Million USD | 28.18% |
| 2022 Q1 | 2.41 Million USD | -61.36% |
| 2022 Q3 | 1.4 Million USD | -17.09% |
| 2022 Q4 | 1.53 Million USD | 9.24% |
| 2022 FY | 7.05 Million USD | -86.67% |
| 2022 Q2 | 1.69 Million USD | -29.64% |
| 2021 Q4 | 6.24 Million USD | -50.99% |
| 2021 Q1 | 15.97 Million USD | 0.93% |
| 2021 Q3 | 12.73 Million USD | -29.1% |
| 2021 FY | 52.91 Million USD | 34.88% |
| 2021 Q2 | 17.96 Million USD | 12.48% |
| 2020 Q4 | 15.82 Million USD | 44.47% |
| 2020 Q3 | 10.95 Million USD | 49.03% |
| 2020 Q2 | 7.35 Million USD | 43.98% |
| 2020 Q1 | 5.1 Million USD | 5.02% |
| 2020 FY | 39.23 Million USD | 167.13% |
| 2019 Q3 | 2.72 Million USD | -17.79% |
| 2019 FY | 14.68 Million USD | 261.93% |
| 2019 Q1 | 3.78 Million USD | 27.41% |
| 2019 Q2 | 3.31 Million USD | -12.37% |
| 2019 Q4 | 4.86 Million USD | 78.32% |
| 2018 Q3 | 1.13 Million USD | 240.96% |
| 2018 Q1 | -376 Thousand USD | -137.41% |
| 2018 FY | 4.05 Million USD | 206.03% |
| 2018 Q2 | 332 Thousand USD | 188.3% |
| 2018 Q4 | 2.97 Million USD | 162.37% |
| 2017 Q2 | 333 Thousand USD | -27.13% |
| 2017 FY | 1.32 Million USD | -44.86% |
| 2017 Q4 | 1 Million USD | 314.29% |
| 2017 Q3 | -469 Thousand USD | -240.84% |
| 2017 Q1 | 457 Thousand USD | -81.71% |
| 2016 Q3 | 83 Thousand USD | 36.07% |
| 2016 FY | 2.4 Million USD | 784.19% |
| 2016 Q4 | 2.49 Million USD | 2910.84% |
| 2016 Q2 | 61 Thousand USD | 125.63% |
| 2016 Q1 | -238 Thousand USD | -149.17% |
| 2015 FY | 272 Thousand USD | -62.69% |
| 2015 Q1 | 27 Thousand USD | -96.28% |
| 2015 Q2 | -57 Thousand USD | -311.11% |
| 2015 Q3 | -182 Thousand USD | -219.3% |
| 2015 Q4 | 484 Thousand USD | 365.93% |
| 2014 Q2 | 45 Thousand USD | 139.13% |
| 2014 FY | 729 Thousand USD | 3936.84% |
| 2014 Q4 | 726 Thousand USD | 2925.0% |
| 2014 Q3 | 24 Thousand USD | -46.67% |
| 2014 Q1 | -115 Thousand USD | -154.5% |
| 2013 FY | -19 Thousand USD | 93.09% |
| 2013 Q4 | 211 Thousand USD | 331.87% |
| 2013 Q1 | -69 Thousand USD | -263.16% |
| 2013 Q2 | -70 Thousand USD | -1.45% |
| 2013 Q3 | -91 Thousand USD | -30.0% |
| 2012 Q1 | -111 Thousand USD | -33.73% |
| 2012 FY | -275 Thousand USD | 9.54% |
| 2012 Q4 | -19 Thousand USD | 66.67% |
| 2012 Q3 | -57 Thousand USD | 35.23% |
| 2012 Q2 | -88 Thousand USD | 20.72% |
| 2011 Q2 | -82 Thousand USD | -134.29% |
| 2011 Q1 | -35 Thousand USD | -220.69% |
| 2011 FY | -304 Thousand USD | -257.51% |
| 2011 Q4 | -83 Thousand USD | 20.19% |
| 2011 Q3 | -104 Thousand USD | -26.83% |
| 2010 Q3 | 5000.00 USD | -91.67% |
| 2010 Q1 | 135 Thousand USD | -23.73% |
| 2010 FY | 193 Thousand USD | -81.1% |
| 2010 Q2 | 60 Thousand USD | -55.56% |
| 2010 Q4 | 29 Thousand USD | 480.0% |
| 2009 Q4 | 177 Thousand USD | -11.5% |
| 2009 Q2 | 210 Thousand USD | -51.61% |
| 2009 Q3 | 200 Thousand USD | -4.76% |
| 2009 Q1 | 434 Thousand USD | -33.54% |
| 2009 FY | 1.02 Million USD | -66.15% |
| 2008 Q3 | 1.86 Million USD | 401.29% |
| 2008 Q2 | -618 Thousand USD | -155.23% |
| 2008 Q1 | 1.11 Million USD | -13.72% |
| 2008 FY | 3.01 Million USD | -51.9% |
| 2008 Q4 | 653 Thousand USD | -64.93% |
| 2007 Q2 | 1.56 Million USD | 14.69% |
| 2007 FY | 6.27 Million USD | 103.04% |
| 2007 Q4 | 1.29 Million USD | -36.3% |
| 2007 Q3 | 2.03 Million USD | 29.76% |
| 2007 Q1 | 1.36 Million USD | 35.45% |
| 2006 Q3 | 904 Thousand USD | 110.48% |
| 2006 Q1 | -8.04 Million USD | 9.43% |
| 2006 FY | 3.08 Million USD | 138.2% |
| 2006 Q4 | 1.01 Million USD | 11.73% |
| 2006 Q2 | -8.62 Million USD | -7.28% |
| 2005 Q1 | -2.77 Million USD | 45.0% |
| 2005 FY | -8.08 Million USD | -64.12% |
| 2005 Q4 | -8.87 Million USD | -35.84% |
| 2005 Q3 | -6.53 Million USD | -40.3% |
| 2005 Q2 | -4.65 Million USD | -68.1% |
| 2004 Q2 | -1.4 Million USD | -2201.49% |
| 2004 FY | -4.92 Million USD | -6666.67% |
| 2004 Q4 | -5.03 Million USD | -297.32% |
| 2004 Q3 | -1.26 Million USD | 9.94% |
| 2004 Q1 | 67 Thousand USD | 116.13% |
| 2003 Q3 | 44 Thousand USD | 0.0% |
| 2003 Q1 | 7637.00 USD | 101.61% |
| 2003 Q2 | - USD | -100.0% |
| 2003 FY | 75 Thousand USD | 33.65% |
| 2003 Q4 | 31 Thousand USD | -29.55% |
| 2002 Q3 | 137.5 Thousand USD | -65.29% |
| 2002 Q4 | -473.77 Thousand USD | -444.54% |
| 2002 Q1 | -3756.00 USD | 0.0% |
| 2002 Q2 | 396.13 Thousand USD | 10646.73% |
| 2002 FY | 56.11 Thousand USD | -82.08% |
| 2001 FY | 313.12 Thousand USD | 0.0% |
| Name | Gross Profit | Gross Profit Difference |
|---|---|---|
| CareCloud, Inc. | 46.24 Million USD | 80.97% |
| Augmedix, Inc. | 21.52 Million USD | 59.119% |
| BrightSpring Health Services, Inc. Common Stock | 1.43 Billion USD | 99.386% |
| CareCloud, Inc. | 46.24 Million USD | 80.97% |
| HealthEquity, Inc. | 622.63 Million USD | 98.587% |
| iCoreConnect Inc. | 6.12 Million USD | -43.734% |
| Inovalon Holdings, Inc. | 499.7 Million USD | 98.239% |
| Nutex Health, Inc. | 34.77 Million USD | 74.694% |
| Omnicell, Inc. | 499.92 Million USD | 98.24% |
| OneMedNet Corporation | -127.9 Thousand USD | 6980.375% |
| Progyny, Inc. | 238.79 Million USD | 96.315% |
| Renalytix Plc | 156 Thousand USD | -5541.026% |
| Schrödinger, Inc. | 140.69 Million USD | 93.745% |
| Simulations Plus, Inc. | 43.15 Million USD | 79.606% |
| SOPHiA GENETICS SA | 42.91 Million USD | 79.493% |
| Streamline Health Solutions, Inc. | 11.54 Million USD | 23.763% |
| Ontrak, Inc. | 8.8 Million USD | 0.0% |
| GE HealthCare Technologies Inc. | 7.92 Billion USD | 99.889% |
| Sharecare, Inc. | 129.49 Million USD | 93.205% |
| Aclarion, Inc. | -324.00 USD | 2716149.383% |
| CareMax, Inc. | 13.9 Million USD | 36.695% |
| Bullfrog AI Holdings, Inc. Common Stock | 59.8 Thousand USD | -14615.719% |
| Forian Inc. | 15 Million USD | 41.35% |
| Bullfrog AI Holdings, Inc. Warrants | 59.8 Thousand USD | -14615.719% |
| HeartBeam, Inc. | - USD | -Infinity% |
| GeneDx Holdings Corp. | 60.62 Million USD | 85.484% |
| SCWorx Corp. | 1.26 Million USD | -593.417% |
| Minerva Surgical, Inc. | 27.24 Million USD | 67.697% |
| Definitive Healthcare Corp. | 203.93 Million USD | 95.685% |
| 10x Genomics, Inc. | 409.31 Million USD | 97.85% |
| Zhongchao Inc. | 8.51 Million USD | -3.381% |
| Accolade, Inc. | 192.06 Million USD | 95.418% |
| MSP Recovery, Inc. | 5.56 Million USD | -58.273% |
| R1 RCM Inc. | 484.5 Million USD | 98.184% |
| Spok Holdings, Inc. | 112.2 Million USD | 92.157% |
| Privia Health Group, Inc. | 161.5 Million USD | 94.551% |
| EUDA Health Holdings Limited | 842.07 Thousand USD | -945.038% |
| TruBridge, Inc. | 163.56 Million USD | 94.62% |
| BrightSpring Health Services, Inc. Tangible Equity Unit | 1.43 Billion USD | 99.386% |
| Sharecare, Inc. | 129.49 Million USD | 93.205% |
| Health Catalyst, Inc. | 131.83 Million USD | 93.325% |
| GoodRx Holdings, Inc. | 683.34 Million USD | 98.712% |
| Premier, Inc. | 840.73 Million USD | 98.953% |
| HealthStream, Inc. | 184.04 Million USD | 95.218% |
| Certara, Inc. | 213.31 Million USD | 95.875% |
| GeneDx Holdings Corp. | 60.62 Million USD | 85.484% |
| SHL Telemedicine Ltd. | 25.26 Million USD | 65.164% |
| CareCloud, Inc. | 46.24 Million USD | 80.97% |
| EUDA Health Holdings Limited | 842.07 Thousand USD | -945.038% |
| HeartBeam, Inc. | - USD | -Infinity% |
| Mangoceuticals, Inc. | 431.5 Thousand USD | -1939.393% |
| CareMax, Inc. | 13.9 Million USD | 36.695% |
| Healthcare Triangle, Inc. | 6.77 Million USD | -29.851% |
| National Research Corporation | 86.66 Million USD | 89.846% |
| Aclarion, Inc. | -324.00 USD | 2716149.383% |
| OptimizeRx Corporation | 42.89 Million USD | 79.487% |